Consideration Sets and Their Role in Modelling Doctor Recommendations About Contraceptives

Health Economics (United Kingdom)

Volumn 26, Issue 1, 2017, Pages 54-73

  Fiebig, Denzil G ^a   Viney, Rosalie ^b   Knox, Stephanie ^c   Haas, Marion ^b   Street, Deborah J ^b   Hole, Arne R ^d   Weisberg, Edith ^e,f   Bateson, Deborah ^e,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c Children's Hospital Westmead   (Australia)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e FAMILY PLANNING NSW   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

consideration sets; contraceptives; doctor recommendations; stated preferences

Indexed keywords

CONTRACEPTIVE AGENT; HORMONE; LOW DOSE ORAL CONTRACEPTIVE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; AUSTRALIA; CLINICAL DECISION MAKING; CONDOM; CONTRACEPTION; CONTRACEPTIVE PATCH; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MALE; MATHEMATICAL MODEL; MIDDLE AGED; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; VAGINA RING; ADOLESCENT; DECISION MAKING; PATIENT REFERRAL; PHYSICIAN; REPRODUCTIVE HEALTH; UTILIZATION;

ADOLESCENT; ADULT; CHOICE BEHAVIOR; CONTRACEPTION; CONTRACEPTIVE AGENTS; FEMALE; HUMANS; PHYSICIANS; REFERRAL AND CONSULTATION; REPRODUCTIVE HEALTH;

EID: 84949522310     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.3276     Document Type: Article

References (36)

1. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group. 2009. ACOG Committee Opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstetrics and Gynecology 114: 1434–1438.
2. Armstrong N, Donaldson C. 2005. The Economics of Sexual Health, Family Planning Association: Newcastle, UK.
3. Belkar R, Fiebig DG, Haas M, Viney R. 2006. Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer. Health Economics 15: 33–47.
4. Britt H, Miller GC, Charles J, Henderson J, Bayram C, Harrison C, Valenti L, Fahridin S, Pan Y, O'Halloran J. 2008. General practice activity in Australia 2007–2008, Australian Institute of Health and Welfare.
5. Brownstone D, Train K. 1999. Forecasting new product penetration with flexible substitution patterns. Journal of Econometrics 89: 109–129.
6. Carson RT, Louviere JJ 2006. Statistical properties of consideration sets, UCSD, Department of Economics, Discussion Paper, 2006–07.
7. Davis P, Gribben B, Scott A, Lay-Yee R. 2000. The ‘supply hypothesis’ and medical practice variation in primary care: testing economic and clinical models of inter-practitioner variation. Social Science and Medicine 50: 407–418.
8. Fiebig DG, Keane MP, Louviere JJ, Wasi N. 2010. The generalized multinomial logit model: accounting for scale and coefficient heterogeneity. Marketing Science 29: 393–421.
9. Fiebig DG, Knox SA, Viney R, Haas M, Street DJ. 2011. Preferences for new and existing contraceptive products. Health Economics 20(S1): 35–52.
10. Geweke J, Gowrisankaran G, Town R. 2004. Bayesian inference for hospital quality in a selection model. Econometrica 71: 1215–1238.
11. Gilbride TJ, Allenby GM. 2004. A choice model with conjunctive, disjunctive, and compensatory decision rules. Marketing Science 23: 391–406.
12. Goeree MS. 2008. Limited information and advertising in the U.S. computer industry. Econometrica 76: 1017–1076.
13. Gray E, McDonald P. 2010. Using a reproductive life course approach to understand contraceptive method use in Australia. Journal of Biosocial Science 42(1): 43–57.
14. Grytten J, Sørensen R. 2003. Practice variation and physician-specific effects. Journal of Health Economics 22: 403–418.
15. Gu Y, Hole AR, Knox S 2013. Estimating the generalized multinomial logit model in Stata. Stata Journal 13: 382–397.
16. Hall JP, King MT, Fiebig DG, Hossain I, Louviere JJ 2006. What influences participation in genetic carrier testing? Results from a discrete choice experiment. Journal of Health Economics 25: 520–537.
17. Hauser JR, Wernerfelt B. 1990. An evaluation cost model of consideration sets. Journal of Consumer Research 16: 393–408.
18. Hole AR 2007. Fitting mixed logit models by using maximum simulated likelihood. Stata Journal 7: 388–401.
19. Hole AR. 2008. Modelling heterogeneity in patients' preferences for the attributes of a general practitioner appointment. Journal of Health Economics 27: 1078–1094.
20. Horowitz, JL, Louviere JJ 1995. What is the role of consideration sets in choice modelling. International Journal of Research in Marketing 12: 39–54.
21. Keane MP, Wasi N. 2013. Comparing alternative models of heterogeneity in consumer choice behaviour. Journal of Applied Econometrics 28: 1018–1045.
22. Knox SA, Viney R, Street D, Haas M, Fiebig DG, Weisberg E, Bateson D. 2012. What's good and bad about contraception? A comparison of the values placed on features of contraceptive products by women consumers and GP providers. PharmacoEconomics 30: 1187–1202.
23. Kuhfeld WF. 2006. Orthogonal arrays, SAS Institute, http://support.sas.com/techsup/technote/ts723.html [Accessed on 7 November 2007].
24. Louviere JJ, Street DJ, Burgess L, Wasi N, Islam T, Marley AAJ. 2008. Modelling the choices of individual decision makers by combining efficient choice experiment designs with extra preference information. Journal of Choice Modelling 1: 128–163.
25. Manski C. 1977. The structure of random utility models. Theory and Decisions 8: 229–254.
26. Revelt D, Train K. 1998. Mixed logit with repeated choices: households' choices of appliance efficiency level. Review of Economics and Statistics 80: 647–657.
27. Roberts JH, Lattin JM. 1991. Development and testing of a model of consideration set composition. Journal of Marketing Research 28: 429–440.
28. Scott A, Shiell A. 1997. Analysing the effect of competition on general practitioners' behaviour using a multilevel modelling framework. Health Economics 6: 577–588.
29. Sonnenberg FA, Burkman RT, Hagerty CG, Speroff L, Speroff T. 2004. Costs and net health benefits of contraceptive methods Contraception 69: 447–459.
30. Street DJ, Burgess L. 2007. The Construction of Optimal Stated Choice Experiments: Theory and Methods, Wiley: Hoboken, NJ.
31. Train KE. 2003. Discrete Choice Methods with Simulation, Cambridge University Press: Cambridge.
32. Wellings K, Zhihong Z, Krentel A, Barrett G, Glasier A 2007. Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 76: 209–214.
33. Wenneberg JE, Barnes BA, Zubkoff M. 1982. Professional uncertainty and the problem of supplier-induced demand. Social Science and Medicine 16: 811–824.
34. Windmeijer F, de Laat E, Douven R, Mot E. 2006. Pharmaceutical promotion and GP prescription behaviour. Health Economics 15: 5–18.
35. Wolff N. 1989. Professional uncertainty and physician medical decision-making in a multiple treatment framework. Social Science and Medicine 28: 99–107.
36. Yusuf F, Siedlecky S. 2007. Patterns of contraceptive use in Australia: Analysis of the 2001 National Health Survey. Journal of Biosocial Science 39: 735–744.